Your browser doesn't support javascript.
loading
Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
Zhao, Xin-Jing; Liu, Xiao-Lin; Liang, Yu-Min; Zhang, Sheng; Liu, Ti; Li, Li-Bo; Jiang, Wen-Guo; Chen, Jin-Jin; Xu, Qiang; Lv, Chen-Long; Jiang, Bao-Gui; Kou, Zeng-Qiang; Wang, Guo-Lin; Fang, Li-Qun.
Afiliación
  • Zhao XJ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Liu XL; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, China.
  • Liang YM; Institute of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
  • Zhang S; Department of Infectious Disease Control and Prevention, Jining Center for Disease Control and Prevention, Jining, China.
  • Liu T; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Li LB; Institute of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
  • Jiang WG; Department of Infectious Disease Control and Prevention, Jining Center for Disease Control and Prevention, Jining, China.
  • Chen JJ; Department of Infectious Disease Control and Prevention, Jining Center for Disease Control and Prevention, Jining, China.
  • Xu Q; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Lv CL; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Jiang BG; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Kou ZQ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
  • Wang GL; Institute of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
  • Fang LQ; State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
J Med Virol ; 96(5): e29640, 2024 May.
Article en En | MEDLINE | ID: mdl-38699969
ABSTRACT
After the termination of zero-COVID-19 policy, the populace in China has experienced both Omicron BA.5 and XBB waves. Considering the poor antibody responses and severe outcomes observed among the elderly following infection, we conducted a longitudinal investigation to examine the epidemiological characteristics and antibody kinetics among 107 boosted elderly participants following the Omicron BA.5 and XBB waves. We observed that 96 participants (89.7%) were infected with Omicron BA.5, while 59 (55.1%) participants were infected with Omicron XBB. Notably, 52 participants (48.6%) experienced dual infections of both Omicron BA.5 and XBB. The proportion of symptomatic cases appeared to decrease following the XBB wave (18.6%) compared to that after the BA.5 wave (59.3%). Omicron BA.5 breakthrough infection induced lower neutralizing antibody titers against XBB.1.5, BA.2.86, and JN.1, while reinfection with Omicron XBB broadened the antibody responses against all measured Omicron subvariants and may alleviate the wild type-vaccination induced immune imprinting. Boosted vaccination type and comorbidities were the significant factors associated with antibody responses. Updated vaccines based on emerging severe acute respiratory syndrome coronavirus 2 variants are needed to control the Coronavirus Disease 2019 pandemic in the elderly.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunización Secundaria / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Aged / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Med Virol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunización Secundaria / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Aged / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Med Virol Año: 2024 Tipo del documento: Article País de afiliación: China
...